Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees

被引：0
|
作者：
Huang, Jennifer Jing
Liang, Emily C.
Albittar, Aya
Portuguese, Andrew Jay
Wuliji, Natalie
Torkelson, Aiko
Kirchmeier, Delaney
Chutnik, Abigail
Pender, Barbara
Shadman, Mazyar
Hirayama, Alexandre V.
Till, Brian G.
Kimble, Erik Lesley
Iovino, Lorenzo
Chapuis, Aude
Otegbeye, Folashade
Cassaday, Ryan Daniel
Milano, Filippo
Maloney, David G.
Gauthier, Jordan
机构：
[1] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7034
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
    Cingireddy, Ananya Reddy
    Flores, Brianna
    Wuthrich, John
    Cingireddy, Anirudh Reddy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [22] Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma
    Samples, Laura S.
    Sadrzadeh, Hossein
    Frigault, Matthew J.
    Jacobson, Caron Alyce
    Hamadani, Mehdi
    Gurumurthi, Ashwath
    Strati, Paolo
    Shouval, Roni
    Riedell, Peter A.
    Dahiya, Saurabh
    Yared, Jean
    Jain, Michael D.
    Locke, Frederick L.
    Leslie, Lori Ann
    Epperla, Narendranath
    Ghosh, Monalisa
    Skarbnik, Alan
    Hill, Brian T.
    Kamdar, Manali K.
    Shadman, Mazyar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy
    Li, Xubin
    Deng, Qing
    Henderson, Jared
    Watson, Grace
    Deaton, Laurel
    Cain, Taylor
    Fayad, Luis
    Iyer, Swaminathan Padmanabhan
    Hagemeister, Fredrick B.
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Westin, Jason
    Steiner, Raphael
    Nair, Ranjit
    Ahmed, Sairah
    Alatrash, Gheath
    Neelapu, Sattva S.
    Strati, Paolo
    Green, Michael R.
    BLOOD, 2022, 140 : 4502 - 4503
  • [24] SALVAGE THERAPIES AND OUTCOMES OF PATIENTS WITH RELAPSE OF B-ALL AFTER CD19 CAR T-CELL THERAPY
    Friedes, Barbara
    DiNofia, Amanda
    Li, Yimei
    Iannone, Emma
    Rheingold, Susan
    Leahy, Allison Barz
    Wray, Lisa
    Callahan, Colleen
    Baniewicz, Diane
    Liu, Hongyan
    Getz, Kelly
    Aplenc, Richard
    Maude, Shannon
    Grupp, Stephan
    Myers, Regina
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S54 - S54
  • [25] Be Cautious to Adopt a Second CAR T-Cell Infusion after Failure of CD19/CD22 Cocktail CAR T-Cell Therapy in Relapsed/Refractory B-NHL
    Yang, Xin
    Wang, Gaoxiang
    Zhang, Xiaoying
    Yu, Qiuxia
    Cao, Yang
    Huang, Liang
    BLOOD, 2022, 140 : 4604 - 4605
  • [26] Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL
    Wang, Gaoxiang
    Huang, Meijuan
    Jiang, Lijun
    Zhang, Xiaoying
    Wang, Zhenhao
    Yu, Qiuxia
    Li, Dengju
    Yang, Yang
    Yang, Xin
    Cao, Yang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (05)
  • [27] The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    Jain, Michael D.
    Faramand, Rawan
    Staedtke, Verena
    Bai, Renyuan
    Lee, Sae Bom
    Kotani, Hiroshi
    Reid, Kayla
    Spitler, Kristen
    Chavez, Julio
    Shah, Bijal
    Bachmeier, Christina A.
    Dam, Marian
    Brandjes, Brigett
    Gonzalez, Ricardo J.
    Mullinax, John E.
    Wang, Xuefeng
    Hussaini, Mohammad
    Locke, Frederick L.
    Davila, Marco L.
    BLOOD, 2019, 134
  • [28] Immune effector cell-associated neurotoxicity syndrome (ICANS) after CD19 CAR-T therapy. A real-world study
    Smith, C. Serra
    Costas, D. Gomez
    Llobell, M. Gomez
    Dominguez, J. Garcia
    Gines, M. Martinez
    Royuela, G. Oarbeascoa
    Almorox, R. Bailen
    Bullido, Y. Fernandez
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 238 - 239
  • [29] EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy
    Zandaki, Dua'a
    Selukar, Subodh
    Bi, Yu
    Li, Ying
    Zinsky, Megan
    Bonifant, Challice L.
    Epperly, Rebecca
    Keerthi, Dinesh
    Triplett, Brandon M.
    Gottschalk, Stephen
    Naik, Swati
    Talleur, Aimee C.
    BLOOD ADVANCES, 2025, 9 (02) : 270 - 279
  • [30] Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with CD19 CAR T-cell lymphoma therapy
    Nie, Esther
    Ahmadian, Saman
    Bharadwaj, Sushma
    Acosta-Alvarez, Lehi
    Threlkeld, Zachary
    Frank, Matthew
    Miklos, David
    Born, Donald
    Scott, Brian
    Monje, Michelle
    Vogel, Hannes
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 464 - 464
12345